Global Pancreatin Market is expected to grow significantly in the coming years owing to the rise in need to treat digestive problems and intestinal gas. Pancreatin is a combination of numerous digestive enzymes that are produced by the exocrine cells of pancreas. Pancreatin is normally obtained from the pancreas of cows or pigs. The mixture is beneficial in treating conditions where pancreatic secretions are inadequate like pancreatitis, pancreatectomy and cystic fibrosis.
Pancreatin is made of pancreatic enzymes amylase, trypsin and lipase. Similar mixture of enzymes is available as pancrelipase, which comprises more active lipase enzyme than pancreatin. The trypsin present in pancreatin performs to hydrolyze amylase hydrolyzes starches in oligosaccharides and the disaccharide maltose, proteins in oligopeptides; and lipase hydrolyzes triglycerides in glycerols and fatty acids. Pancreatin is an effective enzyme supplement that replaces missing pancreatic emzymes and helps in food digestion in case of pancreatic deficiency. Pancreatin decreases the absorption of iron form the food in the duodenum while digestion.
Pancreatic insufficiency is common in young children. In these cases, the pancreas do not produce sufficient quantity of enzymes. Pancreatin include three types of enzyme (lipase, protease, and amylase), that digest the child’s food in the body to ensure good health. Therefore, the rising need for pancreatin to cure the disease in the young children is predicted to drive pancreatin market in the coming years. However, pancreatin may cause side effects like severe nausea, diarrhea, vomiting, severe stomach pain, painful joints, or changes in symptoms. The most common side effects may comprise mild stomach pain, nausea, diarrhea or slight skin rash. All these factors are expected to hamper the growth of pancreatin market in the near future.
The market is categorized on the basis of type, application, and geography. On the basis of type, market is divided into low activity (below 1:10000) and high activity (min. 1:10000). Based on application, market is split into pharmaceuticals, inspection & quarantine, health supplements, and others. Geographically, market is segmented as North America, South America, Europe, Asia Pacific, and Middle East & Africa. The key players in pancreatin market are Shenzhen Hepalink, Nordmark, ALI, Biocatalysts, Bovogen Biologicals, Chongqing Jingkang, Chongqing Aoli, Sichuan Biosyn, Tinshui Chrestensen, Sichuan Deebio, etc.
• Food & Dairy
• North America
• Asia Pacific
• Middle East and Africa
• South America
• Chongqing Aoli
• Chongqing Jingkang
• Shenzhen Hepalink
• Sichuan Deebio
• request free sample to get a complete list of companies
Key Questions Answered in this Report
• What will the market size be in 2022?
• What are the key factors driving the global pancreatin market?
• What are the challenges to market growth?
• Who are the key players in the pancreatin market?
• What are the market opportunities and threats faced by the key players?
Research Support Specialist, USA